These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37048103)

  • 21. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
    Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S
    Technol Cancer Res Treat; 2023; 22():15330338231202391. PubMed ID: 37728167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in the Tumor Microenvironment Mediated by Exosomal MicroRNAs.
    Chu X; Yang Y; Tian X
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
    Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
    Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.
    Yen CH; Hsiao HH
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30405034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome-Transmitted
    Xu H; Han H; Song S; Yi N; Qian C; Qiu Y; Zhou W; Hong Y; Zhuang W; Li Z; Li B; Zhuang W
    Clin Cancer Res; 2019 Mar; 25(6):1923-1935. PubMed ID: 30610101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Latest Findings on the Mechanism of the Interaction Between Multiple Myeloma Cells and Bone Marrow Microenvironment].
    He NH; Zhou W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):475-481. PubMed ID: 37248571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
    Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
    PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the bone marrow microenvironment in multiple myeloma.
    Kawano Y; Moschetta M; Manier S; Glavey S; Görgün GT; Roccaro AM; Anderson KC; Ghobrial IM
    Immunol Rev; 2015 Jan; 263(1):160-72. PubMed ID: 25510276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
    Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
    Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments.
    Nail HM; Chiu CC; Leung CH; Ahmed MMM; Wang HD
    J Biomed Sci; 2023 Aug; 30(1):69. PubMed ID: 37605155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.
    Lam C; Ferguson ID; Mariano MC; Lin YT; Murnane M; Liu H; Smith GA; Wong SW; Taunton J; Liu JO; Mitsiades CS; Hann BC; Aftab BT; Wiita AP
    Haematologica; 2018 Jul; 103(7):1218-1228. PubMed ID: 29622655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promises and challenges of MicroRNA-based treatment of multiple myeloma.
    Tagliaferri P; Rossi M; Di Martino MT; Amodio N; Leone E; Gulla A; Neri A; Tassone P
    Curr Cancer Drug Targets; 2012 Sep; 12(7):838-46. PubMed ID: 22671926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
    Shay G; Hazlehurst L; Lynch CC
    J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
    Ria R; Vacca A
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.
    Pascut D; Pratama MY; Vo NVT; Masadah R; Tiribelli C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of Exosomal miRNA in Multiple Myeloma Progression and Its Possible Mechanism -Review].
    Yang YZ; Zhang XY; Wan Q; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):301-305. PubMed ID: 28245421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extracellular vesicle-mediated drug resistance in multiple myeloma].
    Yamamoto T; Yamamoto Y
    Rinsho Ketsueki; 2023; 64(9):1092-1098. PubMed ID: 37899187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immune microenvironment of multiple myeloma].
    Nakamura K
    Rinsho Ketsueki; 2021; 62(8):1186-1194. PubMed ID: 34497206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Exosomal miRNAs in cancer.
    Li C; Zhou T; Chen J; Li R; Chen H; Luo S; Chen D; Cai C; Li W
    J Transl Med; 2022 Jan; 20(1):6. PubMed ID: 34980158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.